D-1426-2014 Class III Terminated

Recalled by Ferring Pharmaceuticals Inc — Parsippany, NJ

FDA drug recall D-1426-2014 was initiated by Ferring Pharmaceuticals Inc on Sep 19, 2013 and is designated Class III. Reason for recall: Discoloration; due to prolonged heat exposure. The recall status is terminated (terminated Feb 19, 2015). Affected quantity: 72,046 cartons.

Recall details

Product Type
Drugs
Report Date
Jul 16, 2014
Initiation Date
Sep 19, 2013
Termination Date
Feb 19, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
72,046 cartons

Product description

ENDOMETRIN (progesterone) Vaginal Insert 100 mg USP, 21 inserts, Rx Only, Manufactured for: Ferring Pharmaceuticals Inc. Parsippany, NJ 07054 ---- NDC 55566-6500-3

Reason for recall

Discoloration; due to prolonged heat exposure.

Distribution pattern

Nationwide.

Code information

Lot Number:Expiry Date - 0804.182B-1:07/14; 0804.183B-1:07/14; 0804.185A-1:08/14; 0804.186B-1:08/14; 0804.187B-1:08/14; 0804.210A-1:12/14; 0804.212A-1:12/14; 0804.213A-1:12/14; 0804.214A-1:12/14; 0804.216B-1:12/14; 0804.223B-1:02/15 0804.225B-1:03/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1426-2014
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1426-2014. Report a data issue: hello@regdatalab.com.